Efficacy of Venetoclax Combined with Decitabine-Based Treatment for Heavily Pre-Treated Relapsed or Refractory AML Patients in a Real-World Setting.

Juan TongNa ZhaoXing HuWen YaoYaxin ChengLi ZhouHuilan LiuLiangquan GengZimin SunChangcheng Zheng

Published in: Cancer management and research (2021)

The efficacy of venetoclax plus decitabine-based treatment in the real-world treatment of heavily pre-treated RR-AML is similar to that in clinical trials, and the side effects are controllable.

Keyphrases

acute myeloid leukemia
clinical trial
newly diagnosed
ejection fraction
randomized controlled trial
acute lymphoblastic leukemia
combination therapy
diffuse large b cell lymphoma
prognostic factors
patient reported outcomes